Results 121 to 130 of about 603,581 (184)

Lung infection in orally inoculated SARS-CoV-2 hamsters. [PDF]

PLoS One
Picard-Meyer E, Wasniewski M, Boué F, Torres-Maravilla E, Saint-Criq V, Larcher T, Beissat K, Jacouton E, Holowacz S, Waligora-Dupriet AJ, Langella P, Servat A, Monchatre-Leroy E.   +12 more
europepmc   +1 more source

Identification of phytochemical inhibitors of SARS-CoV-2 protease 3CLpro from selected medicinal plants as per molecular docking, bond energies and amino acid binding energies

, 2022
Sami Ullah, Bushra Munir, Abdullah G. Al‐Sehemi, Shabbir Muhammad, Ikram ul Haq, Abida Aziz, Bilal Ahmed, Abdul Ghaffar   +7 more
openalex   +1 more source

Russian SARS-CoV-2 vaccine [PDF]

BMJ, 2020
openaire   +2 more sources

Development of Schamberg's disease after SARS‐CoV‐2 vaccination

Journal of Cutaneous Immunology and Allergy, 2022
Hiroki Morimoto, Yasuaki Ogura, Masaki Otsuka, Satoshi Hayano, Yoshiki Tokura   +4 more
doaj   +1 more source

Decoding the cross-immune pressure: Dengue's role in SARS-CoV-2 evolution. [PDF]

Comput Struct Biotechnol J
Mallick A, Chhajer R, Biswas S.
europepmc   +1 more source

Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects

, 2022
Sara Donzelli, Francesca Spinella, Enea Gino Di Domenico, Martina Pontone, Ilaria Cavallo, Giulia Orlandi, Stefania Iannazzo, Giulio Maria Ricciuto, ISG Virology Covid Team, Raul Pellini, Paola Muti, Sabrina Strano, Gennaro Ciliberto, Fabrizio Ensoli, Stefano Zapperi, Caterina A. M. La Porta, Giovanni Blandino, Aldo Morrone, Fulvia Pimpinelli   +18 more
openalex   +1 more source

SARS-CoV-2 Detection and Persistence in a Remote Amazonian Settlement. [PDF]

J Trop Med
Silva GM, Ilacqua RC, Gonçalves FG, Santana CM, Jordão FT, Prist PR, Nolan MS, Brilhante AF, Sperança MA, Laporta GZ.   +9 more
europepmc   +1 more source

SARS-COV-2 in Argentina

JBRA Assisted Reproduction, 2020
Lancuba, Stella, Martinez, A. Gustavo
openaire   +2 more sources

Novel method for the identification of circulating SARS-CoV-2 variants and clinical characteristics of patient infection with SARS-CoV-2 variants in Central China. [PDF]

Front Cell Infect Microbiol
Yuan Y, Geng Y, Rong T, Wang B, Mao X, Zhang X, Zhang X, Zhang Y, Zheng P, Zhao J, Guo F.   +10 more
europepmc   +1 more source

C > U mutations generate immunogenic peptides in SARS-CoV-2. [PDF]

Nat Commun
Balogh GM, Koncz B, Asztalos L, Ari E, Gémes N, Szebeni GJ, Papp BT, Tóth F, Papp B, Pál C, Manczinger M.   +10 more
europepmc   +1 more source